A recent study reported that pharmaceutical inhibition of PTEN phosphorylation at tyrosine 240 sensitizes GBM cells to radiation by attenuating DNA damage repair mediated by nuclear PTEN [210]. The gene discussed is PTEN; the disease is glioblastoma.